Flowcytometric phenotyping of common variable immunodeficiency

Common variable immunodeficiency (CVID) comprises heterogeneous antibody deficiency disorders. To classify this heterogeneous syndrome, clinical as well as immunologic parameters have been combined. Flowcytometric analysis of circulating T and B lymphocyte subpopulations has become an important tool in this endeavor of disease classification.

[1]  H. Kanegane,et al.  Novel mutations in a Japanese patient with CD19 deficiency , 2007, Genes and Immunity.

[2]  Sue-Jane Lin,et al.  Programmed death-1 (PD-1) defines a transient and dysfunctional oligoclonal T cell population in acute homeostatic proliferation , 2007, The Journal of experimental medicine.

[3]  R. Geha,et al.  Reexamining the role of TACI coding variants in common variable immunodeficiency and selective IgA deficiency , 2007, Nature Genetics.

[4]  B. Mora,et al.  Unravelling the Complexity of T Cell Abnormalities in Common Variable Immunodeficiency1 , 2007, The Journal of Immunology.

[5]  B. Fevang,et al.  Low numbers of regulatory T cells in common variable immunodeficiency: association with chronic inflammation in vivo , 2007, Clinical and experimental immunology.

[6]  K. Warnatz,et al.  Anti-IgA antibodies in common variable immunodeficiency (CVID): diagnostic workup and therapeutic strategy. , 2007, Clinical immunology.

[7]  A. Plebani,et al.  ICOS Deficiency Is Associated with a Severe Reduction of CXCR5+CD4 Germinal Center Th Cells1 , 2006, The Journal of Immunology.

[8]  M. van der Burg,et al.  An antibody-deficiency syndrome due to mutations in the CD19 gene. , 2006, The New England journal of medicine.

[9]  M. van der Burg,et al.  Human ICOS deficiency abrogates the germinal center reaction and provides a monogenic model for common variable immunodeficiency. , 2006, Blood.

[10]  A. Schäffer,et al.  Mutations in TNFRSF13B encoding TACI are associated with common variable immunodeficiency in humans , 2005, Nature Genetics.

[11]  B. Ferry,et al.  Measurement of peripheral B cell subpopulations in common variable immunodeficiency (CVID) using a whole blood method , 2005, Clinical and experimental immunology.

[12]  S. Shurtleff,et al.  Genetic analysis of patients with defects in early B‐cell development , 2005, Immunological reviews.

[13]  A. Plebani,et al.  The loss of IgM memory B cells correlates with clinical disease in common variable immunodeficiency. , 2005, The Journal of allergy and clinical immunology.

[14]  L. Staudt,et al.  Human blood IgM "memory" B cells are circulating splenic marginal zone B cells harboring a prediversified immunoglobulin repertoire. , 2004, Blood.

[15]  R. Carsetti,et al.  Peripheral development of B cells in mouse and man , 2004, Immunological reviews.

[16]  J. Kearney,et al.  Development and selection of marginal zone B cells , 2004, Immunological reviews.

[17]  P. Schneider,et al.  BAFF AND APRIL: a tutorial on B cell survival. , 2003, Annual review of immunology.

[18]  A. Fischer,et al.  Human uracil–DNA glycosylase deficiency associated with profoundly impaired immunoglobulin class-switch recombination , 2003, Nature Immunology.

[19]  B. Piqueras,et al.  Common Variable Immunodeficiency Patient Classification Based on Impaired B Cell Memory Differentiation Correlates with Clinical Aspects , 2003, Journal of Clinical Immunology.

[20]  K. Toellner,et al.  Extrafollicular antibody responses , 2003, Immunological reviews.

[21]  U. Eriksson,et al.  Costimulation through the inducible costimulator ligand is essential for both T helper and B cell functions in T cell–dependent B cell responses , 2003, Nature Immunology.

[22]  A. Schäffer,et al.  Homozygous loss of ICOS is associated with adult-onset common variable immunodeficiency , 2003, Nature Immunology.

[23]  Antonio Lanzavecchia,et al.  Maintenance of Serological Memory by Polyclonal Activation of Human Memory B Cells , 2002, Science.

[24]  A. Denz,et al.  Severe deficiency of switched memory B cells (CD27(+)IgM(-)IgD(-)) in subgroups of patients with common variable immunodeficiency: a new approach to classify a heterogeneous disease. , 2002, Blood.

[25]  S. Shinton,et al.  Resolution of Three Nonproliferative Immature Splenic B Cell Subsets Reveals Multiple Selection Points During Peripheral B Cell Maturation1 , 2001, The Journal of Immunology.

[26]  Massimo Marconi,et al.  Mutations of CD40 gene cause an autosomal recessive form of immunodeficiency with hyper IgM , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[27]  J. Tschopp,et al.  BAFF-R, a Newly Identified TNF Receptor That Specifically Interacts with BAFF , 2001, Science.

[28]  C. Schaniel,et al.  Selection events operating at various stages in B cell development. , 2001, Current opinion in immunology.

[29]  T. Pawson,et al.  ICOS is essential for effective T-helper-cell responses , 2001, Nature.

[30]  P. Lipsky,et al.  Disturbed Peripheral B Lymphocyte Homeostasis in Systemic Lupus Erythematosus1 , 2000, The Journal of Immunology.

[31]  A. Fischer,et al.  Activation-Induced Cytidine Deaminase (AID) Deficiency Causes the Autosomal Recessive Form of the Hyper-IgM Syndrome (HIGM2) , 2000, Cell.

[32]  A. Rolink,et al.  Repertoire selection by pre‐B‐cell receptors and B‐cell receptors, and genetic control of B‐cell development from immature to mature B cells , 2000, Immunological reviews.

[33]  P. Sideras,et al.  B Cell Development in the Spleen Takes Place in Discrete Steps and Is Determined by the Quality of B Cell Receptor–Derived Signals , 1999, The Journal of experimental medicine.

[34]  K. Rajewsky,et al.  Human Immunoglobulin (Ig)M+IgD+ Peripheral Blood B Cells Expressing the CD27 Cell Surface Antigen Carry Somatically Mutated Variable Region Genes: CD27 as a General Marker for Somatically Mutated (Memory) B Cells , 1998, The Journal of experimental medicine.

[35]  A. Rolink,et al.  Characterization of immature B cells by a novel monoclonal antibody, by turnover and by mitogen reactivity , 1998, European journal of immunology.

[36]  R. Bram,et al.  NF-AT activation induced by a CAML-interacting member of the tumor necrosis factor receptor superfamily. , 1997, Science.

[37]  J. Banchereau,et al.  Regulation of B-cell commitment to plasma cells or to memory B cells. , 1997, Seminars in immunology.

[38]  J. Banchereau,et al.  Sequential triggering of apoptosis, somatic mutation and isotype switch during germinal center development. , 1996, Seminars in immunology.

[39]  S. Frøland,et al.  Persistent activation of the tumor necrosis factor system in a subgroup of patients with common variable immunodeficiency--possible immunologic and clinical consequences. , 1996, Blood.

[40]  S. Sato,et al.  The CD19 signal transduction molecule is a response regulator of B-lymphocyte differentiation. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[41]  J. Banchereau,et al.  Generation of memory B cells and plasma cells in vitro , 1995, Science.

[42]  D. Baltimore,et al.  Functional immunoglobulin transgenes guide ordered B-cell differentiation in Rag-1-deficient mice. , 1994, Genes & development.

[43]  S. Frøland,et al.  Elevated serum levels of interleukin-4 and interleukin-6 in patients with common variable immunodeficiency (CVI) are associated with chronic immune activation and low numbers of CD4+ lymphocytes. , 1994, Clinical immunology and immunopathology.

[44]  J. Litzman,et al.  The costimulatory signal CD28 is fully functional but cannot correct the impaired antigen response in T cells of patients with common variable immunodeficiency , 1994, Clinical and experimental immunology.

[45]  M. Eibl,et al.  Defective interleukin-2 and interferon-gamma gene expression in response to antigen in a subgroup of patients with common variable immunodeficiency. , 1993, The Journal of allergy and clinical immunology.

[46]  L. Notarangelo,et al.  Defective expression of T-cell CD40 ligand causes X-linked immunodeficiency with hyper-IgM , 1993, Nature.

[47]  J. Farrant,et al.  Defects in proliferative responses of T cells from patients with common variable immunodeficiency on direct activation of protein kinase C , 1991, Clinical and experimental immunology.

[48]  J. Farrant,et al.  Classification of patients with common variable immunodeficiency by B cell secretion of IgM and IgG in response to anti-IgM and interleukin-2. , 1990, Clinical immunology and immunopathology.

[49]  C. Cunningham-Rundles,et al.  Three distinct stages of B-cell defects in common varied immunodeficiency. , 1982, Proceedings of the National Academy of Sciences of the United States of America.

[50]  H. Kunkel,et al.  Classification of primary immunodeficiencies. , 1973, The New England journal of medicine.

[51]  M. Cooper,et al.  Circulating B-cells in patients with immunodeficiency. , 1972, The American journal of pathology.

[52]  A. Ammann,et al.  SELECTIVE IgA DEFICIENCY: PRESENTATION OF 30 CASES AND A REVIEW OF THE LITERATURE , 1971, Medicine.

[53]  Eren,et al.  The EUROclass trial: defining subgroups in common variable immunodeficiency. , 2008, Blood.

[54]  A. Fischer,et al.  Human models of inherited immunoglobulin class switch recombination and somatic hypermutation defects (hyper-IgM syndromes). , 2004, Advances in immunology.

[55]  Andreas Hutloff,et al.  ICOS is an inducible T-cell co-stimulator structurally and functionally related to CD28 , 1999, Nature.

[56]  I. Maclennan,et al.  Germinal centres in T-cell-dependent antibody responses. , 1992, Immunology today.